Ajanta Pharma Limited (NSEI: AJANTPHARM)
Health Care · Pharmaceuticals · IN
Rs3,581.00
+0.94% today · +49.1% 1Y
Ajanta Pharma Limited (NSEI: AJANTPHARM) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.65B and employs 10,421 people.
Over the last twelve months the share price has gained 49.1%, trading between 2.38K and 3.80K.
Tweenvest scores Ajanta Pharma Limited across four factors: quality 85/100, value 8/100, growth 51/100, dividend 70/100. Its strongest factor is quality.
AJANTPHARM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.65B
- Revenue (TTM)
- $610.90M
- P/E
- 39.44
- EPS
- 90.81
- Dividend yield
- 0.78%
- Beta (5Y)
- 0.22
- 52-week high
- Rs3,796.00
- 52-week low
- Rs2,379.30
- Avg volume (3M)
- —
- Shares outstanding
- 124.94M
- Employees
- 10,421
- Next earnings
- —
About Ajanta Pharma Limited
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
- ISIN
- INE031B01049
- Founded
- 1973
- Listed since
- Jul 1, 2002
- Exchange
- National Stock Exchange of India
- Currency
- INR
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Hanmi Pharm. Co., Ltd.KOSE: A128940 | $4.77B | ₩506,000.00 | -2.69% |
| Definium Therapeutics, Inc.NasdaqGS: DFTX | $4.71B | $34.18 | -2.59% |
| Humanwell Healthcare (Group) Co.,Ltd.SHSE: 600079 | $4.66B | CN¥19.17 | +1.86% |
| Apeloa Pharmaceutical Co.,LtdSZSE: 000739 | $4.66B | CN¥27.74 | +9.64% |
| Sumitomo Pharma Co., Ltd.TSE: 4506 | $4.59B | ¥1,613.50 | +1.16% |
| Hikma Pharmaceuticals PLCLSE: HIK | $4.44B | £16.07 | -2.37% |
| SK Biopharmaceuticals Co., Ltd.KOSE: A326030 | $4.41B | ₩75,800.00 | -0.13% |
| Dottikon ES Holding AGSWX: DESN | $4.38B | CHF256.50 | -3.02% |
Figures last refreshed Oct 4, 2026.